University of Minnesota
Institute for Engineering in Medicine

Unit's home page.




  • Executive Committee
  • Scientific Advisory Board
  • Industrial Advisory Board
  • Industrial Fellows
  • Staff

Executive Committee Alumni

John Bischof, Ph.D.
Director, Institute for Engineering in Medicine,
Distinguished McKnight University Professor,
Carl and Janet Kuhrmeyer Chair, Mechanical Engineering,
Medtronic-Bakken Endowed Chair for Engineering in Medicine


Paul Iaizzo, Ph.D.
Medtronic Endowed Associate Director,
Professional Education and Outreach, Institute for Engineering in Medicine,
Director, Visible Heart Laboratory,
Professor of Surgery


David Odde, Ph.D.
Medtronic Endowed Associate Director,
for Strategy and Innovation, Institute for Engineering in Medicine,
Professor of Biomedical Engineering


Arthur Erdman, Ph.D.
Director, Medical Devices Center;
Richard C. Jordan Professor of Mechanical Engineering


Michael Garwood, Ph.D.
Professor of Radiology


Tom Hays, Ph.D.
Professor, Associate Dean for Research
Genetics, Cell Biology, and Development


David Largaespada, Ph.D.
Director, Brain Tumor Program, Masonic Cancer Center
Associate Director for Basic Sciences, Masonic Cancer Center
Professor of Pediatrics
Professor of Genetics, Cell Biology, and Development


Tay Netoff, Ph.D.
Director, Center for Neuroengineering
Associate Professor of Biomedical Engineering


Brenda Ogle, Ph.D.
Professor, Department of Biomedical Engineering
Stem Cell Institute Leadership Team


Angela Panoskaltsis-Mortari, Ph.D.
Professor, Division of Pediatric Blood and Marrow Transplantation


Theresa Reineke, Ph.D.
Distinguished McKnight University Professor
Professor of Chemistry


Sara Shumway, MD
Professor, Department of Surgery
Vice Chief, Division of Cardiothoracic Surgery
Cardiovascular Surgeon


Scientific Advisory Board Alumni

Rashid Bashir, Ph.D.
Rashid Bashir completed his BSEE from Texas Tech University as the highest ranking graduate in the College of Engineering in Dec 1987. He completed his MSEE from Purdue University in 1989 and Ph.D. from Purdue University in 1992. From Oct 1992 to Oct 1998, he worked at National Semiconductor in the Analog/Mixed Signal Process Technology Development Group where he was promoted to Sr. Engineering Manager. He joined Purdue University in Oct 1998 as Assistant Professor and was later promoted to Professor of Electrical and Computer Engineering and a Courtesy Professor of Biomedical Engineering and Mechanical Engineering. Since Oct 2007, he was the Abel Bliss Professor of Electrical and Computer Engineering & Bioengineering, Director of the Micro and NanoTechnology Laboratory (a campus wide clean room facility) at the University of Illinois, Urbana-Champaign, and Director of the campus-side Center for Nanoscale Science and Technology, a collaboratory aimed to facilitate center grants and large initiatives around campus in the area of nanotechnology. Since Oct. 2013 he has been the Department Head of Bioengineering. He has authored or co-authored over 190 journal papers, over 200 conference papers and conference abstracts, over 120 invited talks, and has been granted 37 patents. He is a fellow of IEEE, AIMBE, AAAS, AIMBE, and APS.

His research interests include BioMEMS, Lab on a chip, nano-biotechnology, interfacing biology and engineering from molecular to tissue scale, and applications of semiconductor fabrication to biomedical engineering, all applied to solve biomedical problems. He has been involved in 2 startups that have licensed his technologies.

In addition to his own research group, he is the PI on an NSF IGERT on Cellular and Molecular Mechanics and Bionanotechnology and PI on an NIH Training Grant on Cancer Nanotechnology. He is also a project lead on an NSF Science and Technology Center on Emergent Behavior of Integrated Biological Systems (headquartered at MIT, and partners at GT and UIUC).

Warren Chan, Ph.D.
Professor Warren Chan is currently a full professor at the Institute of Biomaterials and Biomedical Engineering and Terrence Donnelly Centre for Cellular and Biomolecular Research at the University of Toronto. He received his B.S. and PhD degree, and post-doctoral training from the University of Illinois, Indiana University, and University of California, San Diego.

His research lab is focused on the development of nanoparticles for diagnosing and treating cancer and infectious diseases. Some of the contributions he has made to science and engineering has been (a) the development of quantum dots for biomedical applications, (b) the size and shape dependent cellular interactions of nanoparticles in vitro and in vivo, (c) the identification of the protein corona on nanoparticle and its effect on cancer targeting,[6] and (d) the development of a smartphone-based point of care device for diagnosing infected patients. For his research, he has won many Canadian and International Awards (e.g., NSERC Steacie Fellowship (Canada), International Dennis Gabor Award (Hungary), Rank Prize Fund (UK), and BF Goodrich Young Inventors Award (USA)).

He is currently an Associate Editor of ACS Nano.

Amy E. Herr, Ph.D.
Amy E. Herr is the Lester John & Lynne Dewar Lloyd Distinguished Professor of Bioengineering at the University of California, Berkeley and a Chan Zuckerberg (CZ) Biohub Investigator. Prof. Herr joined UC Berkeley as Assistant Professor of Bioengineering in 2007, was promoted to Associate Professor with tenure in 2012, and promoted to Full Professor in 2015. Prior to joining UC Berkeley, she was a staff member in the Biosystems Research Group at Sandia National Laboratories (Livermore, CA; 2002-2007). She earned her PhD in Mechanical Engineering at Stanford with Profs. Tom Kenny & Juan Santiago as an NSF Graduate Research Fellow, an MS in Mechanical Engineering also from Stanford, and a BS in Engineering & Applied Science from Caltech.

Professor Herr is an elected Fellow of the National Academy of Inventors and the American Institute of Medical and Biological Engineering (AIMBE), a Board Member of the Chemical & Biological Microsystems Society (CBMS) which oversees the microTAS conferences, is a standing member of the NIH Nanotechnology Study Section, and is an Advisory Board Member for the UCSF Rosenman Institute and the journals Analytical Chemistry and ACS Sensors. She has served as a Co-Director of the Cold Spring Harbor Laboratory’s Single Cell Analysis summer course (2015 & 2016), both Chair (2009) and Vice-chair (2007) of the Gordon Research Conference (GRC) on the Physics & Chemistry of Microfluidics. She is faculty advisor to the UC Berkeley chapter of the Society of Women Engineers (SWE) and the Graduate Women in Engineering (GWE).

Professor Herr’s research has been recognized by: the 2016 Mid-career Achievement Award from the American Electrophoresis Society, the 2015 Georges Guiochon Faculty Fellow from HPLC, the 2012 Young Innovator Award from Analytical Chemistry/CBMS, the 2012 Ellen Weaver Award from the Association for Women in Science (AWIS, for mentoring), a 2011 NSF CAREER award, a 2010 NIH New Innovator Award, a 2010 Alfred P. Sloan Research Fellowship in chemistry, a 2010 New Investigator Award in Analytical Chemistry from Eli Lilly & Co., a 2009 Defense Advanced Research Projects Agency (DARPA) Young Faculty Award, a 2009 Hellman Family Faculty Fund Award from UC Berkeley, a 2008 Regents’ Junior Faculty Fellowship from the University of California. Professor Herr has also been recognized by the 2012 Outstanding Instructor Award in Bioengineering (Bioengineering Honor Society student vote) and a 2007 Outstanding Mentor Award from Sandia National Laboratories.

Mehmet Toner, Ph.D.
Mehmet Toner, PhD, was born in Istanbul, Turkey in July 1958. He received a Bachelor of Science degree from Istanbul Technical University in 1983 and a Master of Science degree from the Massachusetts Institute of Technology (MIT) in 1985, both in Mechanical Engineering. He subsequently completed his PhD in Medical Engineering at the Harvard-MIT Division of Health Sciences and Technology (HST) in 1989.

Dr. Toner joined the faculty at the Massachusetts General Hospital and Harvard Medical School as an Assistant Professor of Biomedical Engineering in 1989, and was promoted to Associate Professor in 1996, and to Professor in 2002. Dr. Toner has a joint appointment as a Professor of Health Sciences and Technology at the Harvard-MIT Division of HST.

Dr. Toner serves as a member of the Senior Scientific Staff at the Shriners Hospital for Children. He is a co-founder of the Center for Engineering in Medicine, and founder of the NIH BioMicroElectroMechanical Systems (BioMEMS) Resource Center at the Mass General. He is also the Director of the Biomedical Engineering Research and Education Program for physicians at Mass General.

He has served on many national and international panels and review boards, including National Institutes of Health (NIH) Study Sections, National Science Foundation (NSF) CAREER Award panels, NSF Nanoscience panel, NIH Nanotechnology and Tissue Engineering panel, and several DARPA strategic planning panels.

In 1994, he was recognized by the YC Fung Faculty Award in Bioengineering from the American Society of Mechanical Engineers (ASME). In 1995, he received the Whitaker Foundation Special Opportunity Award. In 1997, he won the John F and Virginia B Taplin Faculty Fellow Award given by Harvard and MIT.

In 1998, Dr. Toner was selected to become a Fellow of the American Institute of Medical and Biological Engineering. He serves on the scientific advisory boards of multiple biotechnology and medical device companies, and has been involved as a scientific founder of multiple startup companies.

Industrial Advisory Board Alumni

J. Fernando Bazan, Ph.D.
CTO, Bio-Techne

Dr. J. Fernando Bazan, Ph.D. has been the Chief Technology Officer of Bio-Techne Corp. since August 1, 2013 and has global recognition as a scientific leader in fields ranging from structural biology to drug discovery for the treatment of human disorders and is instrumental in directing innovation and influencing future growth in Techne's world-wide market. He has more than twenty years of experience in academia and the biotechnology industry, having served as a senior scientist at the DNAX Research Institute and at Genentech as well as Chief Scientific Officer at NeuroScience, Inc., a neuroimmunology startup. Bazan holds an adjunct faculty appointment at the University of Minnesota School of Medicine in the Department of Pharmacology where he applies pharmacological approaches to cancer and immune disorders and utilizes structural and computational insights to investigate signaling mechanisms in biological systems.

As a world renowned scientist, Dr. Bazan has shed light on important biological questions and set the groundwork for advances in the cell signaling and immunology fields. His technical expertise, interdisciplinary approach and creativity led to the first classification system of the structural architectures of cytokines and their receptors. Dr. Bazan's research also produced numerous scientific breakthroughs including the identification of novel cytokines, their receptor complexes and immune subsets (Th17 cells) that responded to these factors. He was trained at Stanford University, the University of California Berkeley and the University of California San Francisco.

Stephanie Board
Vice President, Research and Development

Stephanie Board is the Vice President of Research and Development at Abbott (formerly St. Jude Medical) in the Electrophysiology and Tools division. She has more than 29 years of Health Care experience, more than 20 of which have been at Abbott, leading teams within the Engineering, Preclinical, and Science and Technology areas. Prior to joining Abbott, Board was part of the Research and Development team at Upsher-Smith Laboratories, a pharmaceutical company headquartered in MN. Ms. Board began her career in Clinical Chemistry at Texas Clinical, based in Houston, Texas, shortly after earning a B.S. in Biomedical Science with minors in Chemistry, Biology and Sports Medicine from St. Cloud State University in MN.

Matthew M. Cooper, M.D.
Division Medical Officer, 3M Critical & Chronic Care Solutions Division

Matthew M. Cooper, M.D. is a Medical Officer in the Critical and Chronic Care Solutions division of 3M, providing medical input to our new product development teams whose primary goal is to develop differentiated and clinically relevant products that meet both customer and patient needs. Having specialized in Cardiothoracic Surgery at the New York University School of Medicine, Dr. Cooper has held numerous Medical Director positions around the country, including in the 3M Health Information Systems division and CSL Plasma. Dr. Cooper has been practicing Medicine for over 20 years, but has more recently begun to devote more time to medical device design innovation roles after earning and M.B.A. from the Watson Graduate School of Management in Oklahoma in 2013.

Sebastian Eriksson Giwa, Ph.D.
Cofounder of Osmium Health, Sylvantica Biotech, and Organ Preservation Alliance
Cofounder of Elevian, Ossium Health, Sylvatica Biotech, and the Organ Preservation Alliance (incubated at SU Labs at NASA Research Park).

Prior experience includes investing and research at world leading hedge fund, Bridgewater Associates, consulting and research at Bain and Goldman Sachs and serving two terms as the President of the National Youth Council of Sweden and e.g. directly lobbying the Prime-Minister, EU Commissioners and the UN Secretary General.

Experience also includes successful fundraising from leading VC and industry and unlocking numerous government grants from the NIH and Defense Department for the biotechs I cofounded.

I hold a PhD in Economics (conducted at SSE, Harvard and MIT) and an MBA from Harvard where I graduated with High Distinction and was named a Baker Scholar.

David M. Knapp, Ph.D.
Vice President, Research and Development
Boston Scientific

A leader in the area of Medical Device Development and Exploratory Research, Dave Knapp has been working to treat unmet needs in coronary, cardiovascular and pulmonary medicine for 20 years. Dave’s current focus as Vice President of Corporate Research at Boston Scientific is on developing new solutions and fostering growth in White Space areas. Coordinating open collaborative efforts has been a key focus area, including developing relationships with external institutions and connecting across disciplines and functions to drive meaningful innovation.

Dave has a Bachelor of Science in Chemical Engineering from the University of Michigan, Ann Arbor and a Ph.D. in Chemical Engineering and Materials Science from the University of Minnesota. His undergraduate research focused in the area of cell separation and biochemical engineering at the University of Michigan and MIT, followed by a focus on Tissue Engineering at the University of Minnesota, contributing to deeper understanding of wound healing and developing bio artificial tissues such as liver, artery and heart valve leaflets

Following his tenure as a research scientist and operations engineer at Amoco Oil Company, Dave joined the Corporate Research team at Boston Scientific to help lead a development effort in Drug Eluting Stents. Since then, Dave has held a number of roles within Boston Scientific, spanning from exploratory to commercialization phases of the development cycle for various medical technologies in the cardiovascular space. His current role in Corporate Research focuses on innovation and driving new growth in white space areas and expansion into new geographies.

Tim Laske, Ph.D.
Vice President of Research and Business Development - AF Solutions

Tim Laske is currently the Vice President of Research and Business Development for the AF Solutions Business at Medtronic. He is a Medtronic Bakken Fellow and Technical Fellow and a Fellow of the American Institute for Medical and Biological Engineering. His previous roles at Medtronic include VP of Product Development for AF Solutions, Senior Product Development Director for Heart Valves, Senior Program Director for Transcatheter Valves, Technology Director for Cardiac Rhythm Therapy Delivery, and technology management and design engineering positions in Tachyarrhythmia Lead Development. Prior to his tenure at Medtronic, he worked as a Design Engineer at Ford Motor Company in Detroit in Crash Safety and Advanced Vehicle Systems Engineering.

He has a B.S. degree in both Biological Sciences and Mechanical Engineering from Michigan Technological University. He received his M.S. degree in Mechanical Engineering from the University of Michigan, Ann Arbor, and his Ph.D. in Biomedical Engineering from the University of Minnesota where he serves as an Adjunct Associate Professor in the Department of Surgery. His doctoral research was centered on the use of isolated working hearts in the design of medical devices (Visible Heart®). In addition to medical device design and cardiac physiology, his research interests include the study of hibernation physiology in wild black bear and brown bear populations. He is a founding member of the BioBusiness Alliance of Minnesota, has over 60 U.S. patents, and numerous publications in the field of Biomedical Engineering and Wildlife Biology/Ecology.

Kathleen Motzenbecker
Senior Vice President
The Medical Alley Association

Kathleen Motzenbecker is the Senior Vice President of Medical Alley Association, helping to connect international companies with the U.S. biomedical market through her ample experience with international and U.S. business policy. From 2013 to 2016, Kathleen served as Executive Director of the Minnesota Trade Office in Governor Dayton’s administration, leading multiple trade missions and the establishment of three additional trade offices in Europe and Asia. In 2015, the Minnesota Business Journal named Kathleen one of its “Top 50 Women in Business.” Kathleen received a B.A. in Political Science and Italian from St. Mary’s of Notre Dame in 1991 and a Masters from the Middlebury Institute of International Studies at Monterey in 1997.

Richard Olson
Vice President, Research and Development

Richard Olson is the Vice President of Product Development at Abbott (formerly St. Jude), following his tenure as the Vice President of Research and Development in the same company. In total, Olson has over 20 years of experience in Research and Development, aided by his bachelors in Mechanical Engineering from the University of Wisconsin-Madison and a Masters of Business Administration from the Carlson School of Management.

Sean O’Neil
Vice President, Enterprise Architecture

Sean O’Neil has worked in the Healthcare Insurance industry for the last 21 years, where he has led many transformational technology initiatives ranging from the design and implementation of private clouds to standing up ITIL process and technology stacks. He is also the owner of Rapid eCorp International, LLC, which works to expand access to pharamceuticals in developing markets around the world. O’Neill earned his bachelor’s degree in Anthropology and Arabic, with a concentration in International Development from the University of Minnesota in 1995.

Rhonda Robb
Cardiovascular Systems, Inc.

Rhonda Robb was recently appointed to be the Chief Operating Officer of Cardiovascular Systems, Inc., bringing over 30 years of medical device leadership to practice. Robb formerly served as Vice President and General Manager of the Heart Valve Therapies business at Medtronic. In that role, she was responsible for the transcatheter and surgical valve franchises. Previously, Robb held additional leadership positions in Medtronic’s Coronary, Peripheral and Cardiac Rhythm businesses. She has strong experience leading complex businesses, growing new markets, extensive commercial experience, and a strong track record of building teams and product portfolios that have improved the quality of care for patients with cardiovascular disease. Robb earned a bachelor’s degree from the University of Minnesota and a master’s degree in Business Administration from the Carlson School of Business, at the University of Minnesota.

Randy Schiestl
Vice President, R&D, Global Technology
Boston Scientific

Randall L. Schiestl, PMP, is the Vice President, R&D, Global Technology at Boston Scientific Corporation where he leads a team of talented R&D engineers, scientists and technicians chartered to develop and sustain a broad family of minimally invasive medical devices. Specific responsibilities include: technology management; development systems, product design; computational analysis, packaging, labeling and sterilization engineering; university relationships, new product development facilities and labs; knowledge management; and sustaining engineering. He has global responsibility for building technical community, emerging market sourcing and managing R&D information systems across BSC. His engineering teams are located across multiple facilities both US and OUS.

Mr. Schiestl (Randy) has a BSME degree from the University of Minnesota, College of Science & Engineering, high distinction. He also holds MBA and Executive MBA degrees from the University of Minnesota, Carlson School of Management. Randy has completed the Medical Technology Management mini-MBA at St Thomas University and is certified as a Project Management Professional. Work history includes Honeywell, Alliant Techsystems, and Boston Scientific with functional responsibilities in project and program management, product and process development, strategic planning, mergers and acquisitions, manufacturing management, supply chain, quality, information systems, test facilities, and operations.

Randy serves on multiple local and national industry advisory boards and consortiums including the Medical Devices Industry Consortium, the Medical Industry Leadership Institute, Heart Advisory Committee, AHA Twin Cities Board, Life Science Alley, FIRST Robotics and UMN Biomedical, Medical Device Center, Nanotechnology IABs. He received the 2011 UMAA Alumni Service Award from the University of Minnesota, College of Science & Engineering and the Design of Medical Devices Conference Award in 2012.

Erik Scott, Ph.D.
Director, Advanced Development | RTG Implantables
Bakken Fellow, Technical Fellow at Medtronic
Medtronic, LLC

Erik leads the creation of new platforms for implantable neurostimulators at Medtronic Inc. These platforms enable advanced therapies and features for the patient while exploiting advances in miniaturization of electronics, power sources and mechanical packaging technologies. He has over twenty years of experience in device design for a variety of implanted medical devices, and was the technical lead for Medtronic’s first two generations of implantable lithium ion battery technology. Erik has over 50 patents issued/published and over 40 technical publications.

Erik completed his undergraduate career at St. Olaf College, earning a B.A. in physics and mathematics, before coming to the University of Minnesota, Twin Cities, for his Ph. D. in Materials Science. He has also completed executive development programs at Stanford University and The University of Chicago Booth School of Business in 2013 and 2014, respectively.

Dale Wahlstrom
Founder and CEO
ACT3, LLC Life Science Consulting

Dale Wahlstrom is the President and CEO of Act 3, LLC, a consulting, engineering, and investment firm that focuses on helping companies to expand their global markets, assisting start up companies, and providing unique program management services in the development of capabilities that extend across public private sectors. Act 3 has established an experienced global network of professionals that can be leveraged to meet the needs of virtually any high knowledge content company ranging from an early stage startup to fortune 500 global enterprises.

He has also worked at Medtronic for 24 years, retiring in 2006 after serving as the Vice President of Cardiac Rhythm Disease Management (CRDM) Venture Programs. Prior to this he served as VP/GM of the CRDM Therapy Delivery business. Before Medtronic, he held management and sales positions at Litton Microwave and Burroughs Corporation and managed a clean technology start-up company. Dale has also served as the President and CEO for LifeScience Alley and The BioBusiness Alliance of Minnesota and as the Founding Executive Director of the Medical Device Innovation Consortium (MDIC).

Dale is currently a member of several board of directors, industrial advisory boards, and academic governance boards for different universities and companies, and has received numerous honors for his work, including, most recently, a 2014 fellowship at the American Institute for Medical and Biological Engineering. He currently has eleven patents in medical technology and more pending.

2018 IEM Industrial Fellows

Teresa A. Whitman

Senior Research Manager, Medtronic

Jesus A. Cabrera

Senior Principal Architect, Smiths Medical

Mark Palmer

Senior Principal Scientist, Medtronic

Seb Giwa

Founder and Executive Chairman, Ossium Health

2017 IEM Industrial Fellows

Michael Eggen

Principal Scientist, Medtronic

Sarah Ahlberg

Research Manager, Medtronic

Patrick Parks

Medical Director, 3M Critical and Chronic Care Solutions Division

Sean O’Neil

VP of Enterprise Architecture, Optum

2016 IEM Industrial Fellows

Ed Hedblom

Director of Clinical Research, 3M

Alexander Hill

Research Director, Medtronic

Satish Ramadhyani

Technical Lead, Galil Medical

Kemal Schankereli

CEO, Avalon Medical Ltd.

Ken Merdan

Senior Research and Development Fellow, Boston Scientific

2015 IEM Industrial Fellows

Cynthia Thatcher Clague

Coronary & Structural Heart Research Director, Medtronic

Bruce Forsyth

Research Fellow, Boston Scientific

Gary Leo Hansen

Director of Scientific Affairs, RespirTech

David M. Knapp

VP of Research and Development, Boston Scientific

Jaydeep Kokate

Engineering Director, Boston Scientific

SuPing Lyu

Senior Principal Scientist, Medtronic

Rick D. McVenes

Former Senior Director of Research and Technology, Medtronic

Eric N. Rudie

Founder and CTO, Deneverx LLC

Stephanie Scott


Ken Rosen
Director of Industry & Outreach Programs


Teresa Walbon
Executive Assistant


Qi Shao


Li Zhan


Alicia Buehler
Clinical Immersion Program Intern


Michael Hameister
Graphic designer


Hannah Pichman
Director Office Student Support Intern